Do informed patients have different CIPN outcomes? Results of a Research Advocacy Network survey.

@article{White2016DoIP,
  title={Do informed patients have different CIPN outcomes? Results of a Research Advocacy Network survey.},
  author={Carol B. White and Elda Railey and Robert Bellucci and Cara Thompson},
  journal={Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
  year={2016},
  volume={34 7_suppl},
  pages={60}
}
60 Background: Chemotherapy-induced peripheral neuropathy (CIPN) is common in cancer patients (pts). CIPN impacts quality of life (QoL) and causes emotional distress and treatment (Tx) delays. No agents are recommended for prevention and one agent is recommended for Tx of CIPN (ASCO Guidelines, 2014). Limited data exist about pt experiences with CIPN. The… CONTINUE READING